Journal of Southern Medical University ›› 2004, Vol. 24 ›› Issue (07): 829-831.

Previous Articles     Next Articles

Mifepristone combined with methotrexate for conservative treatment of tubal ectopic pregnancy

LI Zhuo-hua1, QUAN Song2   

  1. 1. 汕头市第二人民医院妇产科, 广东, 汕头, 515011;
    2. 第一军医大学南方医院妇产科, 广东, 广州, 510515
  • Online:2004-07-20 Published:2004-07-20

Abstract: Objective To observe the effects of mifepristone combined with methotrexate for conservative treatment of tubal ectopic pregnancy. Methods A total of 102 cases of tubal ectopic pregnancy diagnosed at early stage were enrolled to receive oral mefepristone at the dose of 75 mg twice daily for 3 d and intramuscular injection with calcium leucovorin at 0.1 mg/kg 24 h after a single dose of methotrexate injection (1 mg/kg· b.w.). In the control group consisting of 86 similar cases, intramuscular injection with calcium leucovorin at 0.1 mg/kg was given 24 h after a single dose of methotrexate (1 mg/kg·b.w.). Results Ninety-four of the 102 cases (92.20%) receiving oral mifepristone combined with calcium leucovorin and methotrexate were cured, a curative rate significantly higher than that in the control group, where 70 cases (81.4%) were cured (P<0.05). Conclusion Mefepristone combined with methotrexate is safe and effective in the treatment of tubal ectopic pregnancy, without obvious side effects.

CLC Number: